hemanshu N. Pandya
President & CEO, Director
pharmaceutical
VENUS PHARMA GmbH
Iraq
Biography
"Mr. Pandya is an experienced pharmaceutical executive with a broad spectrum of commercial, operational, strategic and corporate development experience. Previously, Mr. Pandya was President and Chief Executive Officer of IGI Laboratories Inc. (NYSE AMEX: IG) a provider of topical formulation development, analytical, manufacturing and packaging services to the pharmaceutical industry. Prior to IGI, Mr. Pandya was Chief Operating Officer of NexMed Inc. (now Apricus Biosciences Inc – NASDAQ: APRI), responsible for R&D, Operations, and Corporate Development. He has also served in various senior management roles within the pharmaceutical industry including Senior Vice President of Business Development and Strategic Alliances for Andrx Pharmaceuticals (now Watson Pharmaceuticals – NYSE : WPI), Chief Commercial Officer for Putney, Inc., and senior management roles with Able Laboratories, Inc., Ivax Pharmaceuticals, Inc. (now Teva Pharmaceuticals Industries Limited – NYSE : TEVA) and Faulding/Purepac Pharmaceutical Company (now Actavis, Inc.) "
Research Interest
pharmaceutical science